Active Pharmaceutical Ingredients

The following section deals with Pharmaceutical Ingredients used for manufacturing the medicinal products


Cambrex and AstraZeneca entered a long-term manufacturing agreement

Cambrex Corporation held an opening ceremony with AstraZeneca at its Karlskoga, Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies
DSM Sinochem Pharmaceuticals

DSM Sinochem Pharmaceuticals launches Rosuvastatin in Western Europe

DSM Sinochem Pharmaceuticals has successfully launched its fully backward integrated, generic Rosuvastatin drug product in multiple Western European countries

Croda announces the acquisition of Nautilus Biosciences Canada

Croda International Plc, a British speciality chemicals company, announced that it has acquired Nautilus Biosciences Canada Inc, a technology-rich marine biotechnology company

Siegfried will manufacture API for Keryx Biopharmaceuticals

Keryx Biopharmaceuticals and Siegfried announced they had entered into a Master Manufacturing Services and Supply Agreement
antimicrobial resistance

Novasep will manufacture API for Tetraphase’s novel antibiotic

Novasep announced that it has been selected by Tetraphase for the commercial manufacture of the active pharmaceutical ingredient eravacycline
medicinal cannabis

New Bedrocan production facility manufactures in accordance with GMP

Bedrocan, the world’s most experienced producer of legal medicinal cannabis, meets international pharmaceutical quality and safety requirements


Expert opinion